Acapella: hypogammaglobulinemia and jcv status in ocrelizumab-treated patients, year two data

被引：0
|
作者：
Geils, H. [1 ]
Stribling, I. [1 ]
Katz, J. [1 ]
Lathi, E. [1 ]
Douglas, E. [1 ]
Bouley, A. [1 ]
机构：
[1] Elliot Lewis Ctr MS Care, Wellesley, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0280
引用
收藏
页码：256 / 256
页数：1
相关论文
共 50 条
  • [1] ACAPELLA: hypogammaglobulinemia and JCV status in ocrelizumab-treated patients, year four data
    Douglas, E.
    Jungquist, R. -M.
    Bouley, A.
    Katz, J.
    Lathi, E.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 645 - 645
  • [2] ACAPELLA: Hypogammaglobulinemia and JCV status in Ocrelizumab-Treated Patients, Late Breaking Data
    Douglas, E.
    O'Shea, I.
    Bouley, A.
    Katz, J.
    Lathi, E.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 1000 - 1000
  • [3] ACAPELLA: Hypogammaglobulinemia in Ocrelizumab-Treated Patients, Year Six Data
    O'Shea, Isabella
    Douglas, Elizabeth
    Greenawalt, Paige
    Bouley, Andrew
    Lathi, Ellen
    Katz, Joshua
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 361 - 361
  • [4] Acapella: b-cell reconstitution in ocrelizumab-treated patients
    Stribling, I.
    Geils, H.
    Katz, J.
    Lathi, E.
    Douglas, E.
    Bouley, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 255 - 255
  • [5] Acapella: B-cell repletion in ocrelizumab-treated patients
    Jungquist, R. -M.
    Douglas, E.
    Bouley, A.
    Katz, J.
    Lathi, E.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 660 - 661
  • [6] Hypogammaglobulinemia and Infection Risk in an Ocrelizumab-treated Multiple Sclerosis Cohort
    Nobile, Steven
    Beauchemin, Philippe
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2024,
  • [7] ACAPELLA: Real-World Experience with Ocrelizumab, 6-Year Data
    Douglas, Elizabeth
    O'Shea, Isabella
    Greenawalt, Paige
    Bouley, Andrew
    Lathi, Ellen
    Katz, Joshua
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 979 - 980
  • [8] JCV serostatus and viral replication in patients with Multiple Sclerosis treated with Ocrelizumab
    Landi, D.
    Grimaldi, A.
    Prezioso, C.
    Ciotti, M.
    Iannetta, M.
    Castelli, M.
    Cola, G.
    Nicoletti, C. G.
    Mataluni, G.
    Pietropaolo, V.
    Marfia, G. A.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 342 - 342
  • [9] MANUSCRIPT: long-term surveillance of ocrelizumab-treated patients with multiple sclerosis
    Wormser, D.
    Butzkueven, H.
    Hillert, J.
    Magyari, M.
    Trojano, M.
    Vukusic, S.
    Ferreira, G.
    Wang, Q.
    Stokmaier, D.
    Ziemssen, T.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 871 - 871
  • [10] Cases reported as progressive multifocal leukoencephalopathy in Ocrelizumab-treated patients with multiple sclerosis
    Clifford, D. B.
    Gass, A.
    Richert, N.
    Tornatore, C.
    Vermersch, P.
    Hughes, R.
    Koendgen, H.
    Gold, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 509 - 509
12345